THE OLOROFIM DIARIES

The study doctor will check with you about all of the probable Unintended effects of treatment method. You’ll have a chance to talk to any issues you may have.have intermediate 2 or large risk myelofibrosis and have not had a JAK2 inhibitor drug like ruxolitinib More details on this trialThe chance or severity of methemoglobinemia may be improved